First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
September 07, 2021 08:30 ET | University of Minnesota Medical School
MINNEAPOLIS/ST. PAUL, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use...
Focusing on Solution
Focusing on Solutions to the Opioid Crisis, Foundation for Opioid Response Efforts (FORE) Announces Family- and Community-Based Initiatives to Prevent Substance Use Disorder and Overdose
July 20, 2021 11:00 ET | Foundation for Opioid Response Efforts
New York, July 20, 2021 (GLOBE NEWSWIRE) -- It is estimated that one in eight (8.7 million) children ages 17 or younger in the United States live in a household where at least one parent has had a...
22157.jpg
Insights on the Mental Health Disorder Pharmaceutical Treatments Global Market to 2025 - Players Include Eli Lilly, Johnson & Johnson and Pfizer Among Others
February 26, 2021 05:38 ET | Research and Markets
Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Treatments for Mental Health Disorders: Global Markets" report has been added to ResearchAndMarkets.com's offering. This new report...
UPMC Center for High
UPMC Center for High-Value Health Care Awarded $1 Million to Support Substance Use Disorder Care in Bedford and Somerset Counties
September 21, 2020 10:42 ET | UPMC Health Plan
PITTSBURGH, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The UPMC Center for High-Value Health Care (Center), a nonprofit research organization housed within UPMC Health Plan, was awarded $1 million from the...
Delaware Grows Partn
Delaware Grows Partnership with Appriss Health to Integrate Prescription Monitoring Program Into its Electronic Health Record System via PMP Gateway Solution
June 24, 2020 10:00 ET | Appriss Health
Louisville, KY and Dover, DE, June 24, 2020 (GLOBE NEWSWIRE) -- LOUISVILLE, KY & DOVER, DE – June 22, 2020 – Appriss Health, provider of the most comprehensive platform for opioid stewardship...
TRHC-logo fin.png
TRHC Praises Signing of SUPPORT for Patients and Communities Act
November 01, 2018 08:00 ET | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, applauds the signing...
Addiction Policy For
Addiction Policy Forum Launches “How Do You Really Keep Your Kids Safe From Addiction?”
October 23, 2018 03:01 ET | Addiction Policy Forum
Washington, DC, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Addiction Policy Forum, a leading addiction nonprofit, has developed the “How Do You Really Keep Your Kids Safe From Addiction?” toolkit to support...
CareFirst to Invest
CareFirst to Invest $1.5 Million to Increase Substance Use Disorder Services
April 09, 2018 11:06 ET | CareFirst BlueCross BlueShield
Baltimore, Md., April 09, 2018 (GLOBE NEWSWIRE) -- CareFirst BlueCross BlueShield (CareFirst), the region’s largest not-for-profit insurer, plans to award $1.5 million over two years to programs...
Appriss Health Partn
Appriss Health Partners with ClariCare to Deliver Prescription Drug Monitoring Program Information and Advanced Analytics to Dentists through an Integrated Solution to Aid in Appropriate and Safe Prescribing Practices
February 14, 2018 15:53 ET | Appriss Health
Louisville, KY, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Appriss Health, provider of the most comprehensive platform for substance use disorder (SUD) in the U.S., today announced a successful pilot that...
Appriss Health Partn
Appriss Health Partners with Kansas to Integrate K-TRACS Prescription Drug Monitoring Program Data Into Electronic Health Records and Pharmacy Management Systems Statewide
September 19, 2017 14:00 ET | Appriss Health
Louisville, KY, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Appriss Health, provider of the most comprehensive platform for substance use disorder in the U.S., today announced that it has entered into an...